Clinical Trial Update: Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated alternative dosing of exemestane before surgery in postmenopausal women with early-stage estrogen receptor-positive breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Exemestane (Exemestane)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2023-08-22